300 related articles for article (PubMed ID: 37297603)
1. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
[TBL] [Abstract][Full Text] [Related]
2. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
[TBL] [Abstract][Full Text] [Related]
3. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
[TBL] [Abstract][Full Text] [Related]
4. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
Wallace B; van Roode T; Pagan F; Hore D; Pauly B
BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
[TBL] [Abstract][Full Text] [Related]
5. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
[TBL] [Abstract][Full Text] [Related]
6. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
Wallace B; van Roode T; Burek P; Hore D; Pauly B
Harm Reduct J; 2022 Dec; 19(1):143. PubMed ID: 36539747
[TBL] [Abstract][Full Text] [Related]
7. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
8. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
9. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.
Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S
Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980
[TBL] [Abstract][Full Text] [Related]
10. A qualitative assessment of key considerations for drug checking service implementation.
Grace Rose C; Pickard AS; Kulbokas V; Hoferka S; Friedman K; Epstein J; Lee TA
Harm Reduct J; 2023 Oct; 20(1):151. PubMed ID: 37848875
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
Santelices C; Matsumoto A; Boulad M; Stopka TJ
Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
[No Abstract] [Full Text] [Related]
12. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
Carroll JJ; Mackin S; Schmidt C; McKenzie M; Green TC
Harm Reduct J; 2022 Feb; 19(1):9. PubMed ID: 35120531
[TBL] [Abstract][Full Text] [Related]
13. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
[No Abstract] [Full Text] [Related]
14. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
15. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
[TBL] [Abstract][Full Text] [Related]
16. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
18. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
[TBL] [Abstract][Full Text] [Related]
19. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.
Collins AB; Boyd J; Mayer S; Fowler A; Kennedy MC; Bluthenthal RN; Kerr T; McNeil R
Int J Drug Policy; 2019 Nov; 73():199-207. PubMed ID: 31542327
[TBL] [Abstract][Full Text] [Related]
20. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
